insights_auto
Why is RGEN down 4.37%?
Dive Deeperchevron_right
RGEN:NASDAQ
Repligen Corp
$167.22
arrow_downward
-4.37%(-7.64) 1D
$167.22
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 7, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for RGEN...
Open
$174.75
High
$175.04
Low
$165.99
Mkt. cap
10.62B
Avg. vol.
1.10M
Volume
2.63M
P/E ratio
227.94
52-wk high
$198.86
52-wk low
$100.99
EPS
$0.73
Beta
1.08
Shares outstanding
56.44M
No. of employees
2K
Open
$174.75
High
$175.04
Low
$165.99
Mkt. cap
10.62B
Avg. vol.
1.10M
Volume
2.63M
P/E ratio
227.94
52-wk high
$198.86
52-wk low
$100.99
EPS
$0.73
Beta
1.08
Shares outstanding
56.44M
No. of employees
2K
News stories
From web sources and news partners
Stock Titan
·
7 hours ago
One holder reports no voting power in Repligen (RGEN), despite a 7.36M-share passive stake.
GuruFocus
·
1 day ago
Repligen Corp (RGEN) Shares Fall 7.7% -- What GF Score of 85 Tel
Investing.com
·
1 day ago
Repligen CEO Olivier Loeillot sells $1.03m of company stock
Investing.com UK
·
1 day ago
Form 4 Repligen Corporation For: 6 October By Investing.com
Profile
Repligen Corporation is an American life sciences company that develops and manufactures products used in biological drug manufacturing. The company is headquartered in Waltham, Massachusetts, and is listed on the Nasdaq under the symbol RGEN. Wikipedia
About Repligen Corp
CEOTony J. Hunt
Employees2K
Founded1981
HeadquartersWaltham, Massachusetts, United States
SectorHealth care
Websiterepligen.com